Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WA | N.MMED.WR | N.MMED.WS | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by josameyeron Oct 25, 2012 11:46am
408 Views
Post# 20523144

Further updates on current drilling

Further updates on current drilling

 Recent results for Zone 147 GF12-581 ( 57 m core width  5.17g at a vertical depth of 280 m). Contact zone GF12-376 Core width 20 m 4.79 G at a depth of 425 m.With the recent discovery of the Grey Fox south zone, Brigus looks forward to demonstrating a significantly larger gold resource durig 2013.This is in conjuntion with ongoing drilling at the contact and the 147 zone.All zones remain open for expansion.Further, the Black Fox orebody remains also open at depth and along strike and currently includes gold reserves to a maximum depth of 500 metres.The ongoing underground drilling at Black Fox will drill beyond te 500 metres. Ore bodies in the region, along the Destor Porcupine Fault often extend to depth o more than 1000 metres.I hope that the foregoing maybe of interest to some. In the meanwile do your own DD. As always, have a great day, josa.

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse